Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 9INDUSTRY 3OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1

Interventions

Azacitidine 4fludarabine 3venetoclax 2bisantrene 2Cyclophosphamide 2Clofarabine 2vosaroxin 1treosulfan 1liposomal amphotericin B 1defactinib 1decitabine and cedazuridine drug combination 1cedazuridine 1cc-486 1Thalidomide 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Interleukin-2 1Idarubicin 1Human Papillomavirus Recombinant Vaccine nonavalent 1Filgrastim 1Everolimus 1Dexamethasone 1Decitabine 1Daunorubicin 1Dasatinib 1Cytarabine 1Cyclosporine 1Control Groups 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Leukemia, Myeloid, Acute × treosulfan × Clear all
NCT00491634 2015-12-02

Treosulfan-based Conditioning for Transplantation in AML/MDS

Sheba Medical Center

Phase 2 Completed
24 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡